Old Web
English
Sign In
Acemap
>
Paper
>
BIOM-31. ERK1/2 PHOSPHORYLATION PREDICTS SURVIVAL FOLLOWING ANTI-PD-1 IMMUNOTHERAPY IN RECURRENT GLIOBLASTOMA
BIOM-31. ERK1/2 PHOSPHORYLATION PREDICTS SURVIVAL FOLLOWING ANTI-PD-1 IMMUNOTHERAPY IN RECURRENT GLIOBLASTOMA
2021
Victor A Arrieta
Andrew X. Chen
J. Robert Kane
Seong Jae Kang
Cynthia Kassab
Crismita Dmello
Junfei Zhao
Kirsten Bell Burdett
Pavan S. Upadhyayula
Catalina Chang
Joseph Shilati
Dinesh Jaishankar
Li Chen
Andrew Gould
Daniel Zhang
Jinzhou Yuan
Wenting Zhao
Xiaoyang Ling
Jared K Burks
Brice Laffleur
Christina Amidei
Jeffrey N. Bruce
Rimas V. Lukas
Jonathan T. Yamaguchi
David Cieremans
Gerson Rothschild
Uttiya Basu
Matthew R McCord
Daniel J. Brat
Hui Zhang
Lee Cooper
Bin Zhang
Peter A. Sims
Timothy F. Cloughesy
Robert M. Prins
Peter Canoll
Roger Stupp
Amy B Heimberger
Craig Horbinski
Fabio M. Iwamoto
Raul Rabadan
Adam M. Sonabend
Keywords:
Cancer research
Phosphorylation
Immunohistochemistry
Immunotherapy
Cancer
Microglia
Cell cycle checkpoint
Medicine
Extracellular matrix-cell signaling
Signal transduction
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]